Healthcare AI & Digital Health
AI-generated weekly research reports from primary sources. · 24 reports
Healthcare AI & Digital Health
The week of September 21–27, 2026 was defined by a sharpening AI accountability reckoning across the healthcare system: BCBSA quantified $942 million in AI-driven coding cost inflation with no clinica…
Healthcare AI & Digital Health
The week of September 14–20, 2026 was defined by a convergence of landmark regulatory actions and mounting governance tensions in healthcare AI. The FDA approved the first gene therapy for Sanfilippo …
Healthcare AI & Digital Health
The week of September 6–13, 2026 was defined by three converging forces: the UK's rapid progression from AI regulatory frameworks to a published NHS commission blueprint for safe AI adoption; Japan's …
Healthcare AI & Digital Health
The first week of September 2026 delivered continued FDA first-in-class approvals including the first drug for Alexander disease, while the AMA institutionalized AI governance leadership, Medtronic an…
Healthcare AI & Digital Health
July–August 2026 was defined by an unprecedented FDA first-in-class approval surge spanning oncology, rare disease, neurology, and diagnostics, while healthcare AI governance crystallized from policy …
Healthcare AI & Digital Health
The week of August 24–30, 2026 was defined by an exceptional cluster of FDA first-in-class approvals spanning oncology, rare disease, wearable diagnostics, and autoimmune conditions; a wave of medtech…
Healthcare AI & Digital Health
The week of August 17-23, 2026 was defined by three converging forces: a worsening public health crisis as the Cyclospora outbreak surpassed 10,930 cases and FDA expanded inspections into Mexico; a pi…
Healthcare AI & Digital Health
Week 2 of August 2026 saw the Cyclospora outbreak nearly double to 9,481 cases, the MHRA become the first in Europe to authorize an oral GLP-1 drug, Bristol Myers Squibb win a first-in-class FDA appro…
Healthcare AI & Digital Health
The week of August 3–10, 2026 was defined by a high-velocity FDA approval cadence spanning neurology, oncology, and emergency medicine; continued AI investment in clinical trial simulation and health …
Healthcare AI & Digital Health
The week of July 27 – August 2, 2026 was marked by the MHRA's launch of a pioneering AI health regulatory sandbox, the FDA's first-ever freeze-dried plasma product license, a $1.6 billion Salesforce V…
Healthcare AI & Digital Health
July 2026 marked an accelerating convergence of FDA approval momentum, large-scale AI infrastructure investment, and intensifying regulatory scrutiny across digital health, pharma manufacturing, and a…
Healthcare AI & Digital Health
Week 4 of July 2026 brought significant developments across digital health regulation, AI platform expansion, public health emergencies, and pharmaceutical approvals. The FDA launched the TEMPO digita…
Healthcare AI & Digital Health
Week 3 of July 2026 brought a landmark FDA cardiovascular approval, a major CMS regulatory threat to remote patient monitoring, record digital health funding data for H1 2026, Eli Lilly's entry into p…
Healthcare AI & Digital Health
Week 2 of July 2026 saw accelerating regulatory activity across the FDA, MHRA, PMDA, and WHO, while healthcare AI investment deepened through major M&A and fundraising, and biotech pipeline competitio…
Healthcare AI & Digital Health
The week of July 1–5, 2026 saw a rapid cadence of landmark regulatory approvals across the FDA, MHRA, and PMDA, accompanied by major AI investment commitments in specialty pharmacy and pharma research…
Healthcare AI & Digital Health
June 2026 marked a pivotal month for healthcare AI and digital health, defined by simultaneous multi-jurisdictional AI governance formalization, an accelerating wave of FDA and MHRA regulatory moderni…
Healthcare AI & Digital Health
The week of June 21–27, 2026 saw healthcare AI face mounting scrutiny over real-world deployment failures, while concurrent public health emergencies escalated with Europe's first imported Ebola case,…
Healthcare AI & Digital Health
The week of June 14–20, 2026 saw accelerating multi-jurisdictional AI governance activity alongside significant FDA approvals, a new MHRA-FDA liaison programme, escalating public health emergencies, a…
Healthcare AI & Digital Health
The week of June 9–13, 2026 saw major advances in healthcare AI governance and digital health regulation, with the MHRA launching two AI regulatory sandboxes, the FDA clearing the first OTC continuous…
Healthcare AI & Digital Health
The week of June 2–5, 2026 saw a wave of regulatory advancements and digital health launches, including new FDA draft guidance to accelerate cell and gene therapies, multiple MHRA drug authorizations,…
Healthcare AI & Digital Health
During the week of May 29–June 4, 2026, global healthcare regulators accelerated digital transformation and drug development modernization, with the FDA issuing draft guidance to reduce animal testing…
Healthcare AI & Digital Health
The May 22–28, 2026 reporting period is marked by the FDA's historic first approval for chronic Hepatitis Delta Virus infection, accelerating AI integration across regulatory and clinical sectors, and…
Healthcare AI & Digital Health
The week of May 15–21, 2026 saw significant regulatory and global health developments, including the WHO declaring the DRC Ebola outbreak a Public Health Emergency of International Concern, new MHRA r…
Healthcare AI & Digital Health
This baseline snapshot covers Healthcare AI and Digital Health developments from early-to-mid May 2026, highlighting accelerating regulatory modernization across the FDA, MHRA, and PMDA, alongside a w…